GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Minerva Surgical Inc (OTCPK:UTRS) » Definitions » Total Assets

Minerva Surgical (Minerva Surgical) Total Assets : $72.79 Mil (As of Sep. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Minerva Surgical Total Assets?

Minerva Surgical's Total Assets for the quarter that ended in Sep. 2023 was $72.79 Mil.

During the past 12 months, Minerva Surgical's average Total Assets Growth Rate was -10.20% per year. During the past 3 years, the average Total Assets Growth Rate was 46.80% per year.

During the past 4 years, Minerva Surgical's highest 3-Year average Total Assets Growth Rate was 46.80%. The lowest was 46.80%. And the median was 46.80%.

Total Assets is connected with ROA %. Minerva Surgical's annualized ROA % for the quarter that ended in Sep. 2023 was -37.77%. Total Assets is also linked to Revenue through Asset Turnover. Minerva Surgical's Asset Turnover for the quarter that ended in Sep. 2023 was 0.16.


Minerva Surgical Total Assets Historical Data

The historical data trend for Minerva Surgical's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Minerva Surgical Total Assets Chart

Minerva Surgical Annual Data
Trend Dec19 Dec20 Dec21 Dec22
Total Assets
46.68 92.05 115.09 68.90

Minerva Surgical Quarterly Data
Dec19 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 83.80 68.90 85.17 79.30 72.79

Minerva Surgical Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Minerva Surgical's Total Assets for the fiscal year that ended in Dec. 2022 is calculated as

Total Assets=Total Equity (A: Dec. 2022 )+Total Liabilities (A: Dec. 2022 )
=17.181+51.719
=68.90

Minerva Surgical's Total Assets for the quarter that ended in Sep. 2023 is calculated as

Total Assets=Total Equity (Q: Sep. 2023 )+Total Liabilities (Q: Sep. 2023 )
=20.255+52.53
=72.79

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Minerva Surgical  (OTCPK:UTRS) Total Assets Explanation

Total Assets is connected with ROA %.

Minerva Surgical's annualized ROA % for the quarter that ended in Sep. 2023 is

ROA %=Net Income (Q: Sep. 2023 )/( (Total Assets (Q: Jun. 2023 )+Total Assets (Q: Sep. 2023 ))/ count )
=-28.724/( (79.303+72.785)/ 2 )
=-28.724/76.044
=-37.77 %

Note: The Net Income data used here is four times the quarterly (Sep. 2023) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Minerva Surgical's Asset Turnover for the quarter that ended in Sep. 2023 is

Asset Turnover
=Revenue (Q: Sep. 2023 )/( (Total Assets (Q: Jun. 2023 )+Total Assets (Q: Sep. 2023 ))/ count )
=11.965/( (79.303+72.785)/ 2 )
=11.965/76.044
=0.16

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Minerva Surgical Total Assets Related Terms

Thank you for viewing the detailed overview of Minerva Surgical's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Minerva Surgical (Minerva Surgical) Business Description

Traded in Other Exchanges
N/A
Address
4255 Burton Drive, Santa Clara, CA, USA, 95054
Minerva Surgical Inc is a medical device company that develops therapeutic devices that treat abnormal uterine bleeding in a minimally invasive manner. The Company operates and manages its business as one reportable and operating segment, which is the business of research, development, and sale of therapeutic devices for abnormal uterine bleeding treatment.
Executives
Daniel Cohen director C/O ACCELMED, 848 BRICKELL AVE, #901, MIAMI FL 33131
Accelmed Partners Ii L.p. 10 percent owner 2875 NE 191ST, SUITE 500, AVENTURA FL 33180
New Enterprise Associates 13 Lp 10 percent owner 1119 ST PAUL STREET, BALTIMORE MD 21202
Uri Geiger director, 10 percent owner 221 LATHROP WAY, SUITE I, SACRAMENTO CA 95815
Todd Usen director, officer: Chief Executive Officer C/O MINERVA SURGICAL, INC., 4255 BURTON DRIVE, SANTA CLARA CA 95054
Derrick Sung director C/O IRHYTHM TECHNOLOGIES, INC., 650 TOWNSEND STREET, SUITE 380, SAN FRANCISCO CA 94103
David M Clapper director, officer: President and CEO 3003 TASMAN DRIVE, SANTA CLARA CA 95054
Novo Holdings A/s 10 percent owner TUBORG HAVNEVEJ 19, HELLERUP G7 2900
Jaffe Ross A Md director ONE SANSOME STREET, SUITE 3630, SAN FRANCISCO CA 94104
Evgueni V. Skalnyi officer: VP Medical Affairs C/O MINERVA SURGICAL, INC., 4225 BURTON DRIVE, SANTA CLARA CA 95054
Dominique J. Filloux officer: COO C/O MINERVA SURGICAL, INC., 4225 BURTON DRIVE, SANTA CLARA CA 95054
Joel R Jung officer: CFO 1401 HARBOR BAY PARKWAY, ALAMEDA CA 94502
Niquette L. Hunt director SOLITON, INC., 5304 ASHBROOK DRIVE, HOUSTON TX 77081
Jill Anderson director 1600 WEST MERIT PARKWAY, SOUTH JORDAN UT 84095
Nea Partners 13, Limited Partnership 10 percent owner 1119 ST. PAUL STREET, BALTIMORE MD 21202

Minerva Surgical (Minerva Surgical) Headlines

From GuruFocus

Minerva Surgical Announces Time To Talk Campaign

By PurpleRose PurpleRose 08-03-2022

Minerva Surgical to Present at Upcoming Investor Conferences

By GuruFocusNews GuruFocusNews 06-29-2022

Minerva Surgical to Present at Upcoming Investor Conferences

By GuruFocusNews GuruFocusNews 05-20-2022

Minerva Surgical to Present at the 41st Annual J.P. Morgan Healthcare Conference

By Stock market mentor Stock market mentor 01-03-2023

Minerva Surgical to Present at Upcoming Investor Conferences

By GuruFocusNews GuruFocusNews 06-09-2022

Minerva Surgical to Present at Upcoming Investor Conferences

By GuruFocusNews GuruFocusNews 06-19-2022

Top 5 1st Quarter Trades of Versant Venture Management, LLC

By GuruFocus Research GuruFocus Editor 05-11-2022